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Abstract  
Background Colorectal cancer is the third leading cause of death from cancer in adults in the United 
States, with increasing prevalence in other countries. Radical resection is the gold standard of 
treatment in most cases of colorectal cancer, with a high rate of postoperative complications. 
Perioperative probiotics can improve the immune response and the postoperative intestinal 
microbiota environment. Although several studies have shown the benefits of probiotics in 
preventing postoperative complications of infection, the administration of perioperative probiotics 
in colorectal cancer patients is still controversial.  
Objective. The purpose of this critical appraisal is to know the effectiveness of administering 
probiotics to prevent infectious complications in colorectal cancer patients. 
Methods. Literature research using Pubmed, Cochrane, and EBSCOhost was carried out and 2 
articles were obtained in the form of meta-analysis using STATA v11 and Revman v5.2 that was 
critically examined using the FAITH method. A comprehensive search for all studies was done to 
find all relevant studies using both MeSH terms and text words. The article should describe the 
assessment of quality and criteria used in method section, also provide information on the quality 
of individual studies in result section to minimize bias. The result section should state whether 
heterogeneity exists and mention possible reasons. 
Results. Based on 2 meta-analyses that have been critically examined, which each consisting of 13 
and 7 studies, giving probiotics can reduce the overall infection rate after colorectal cancer surgery. 
One meta-analysis showed an odds ratio (OR) of 0.51 (95% CI: 0.38 – 0.68, p = 0.00). Probiotics, 
such as Lactobacillus acidophilus and Bifidobacterium longum can also reduce the incidence of 
surgical site infections (OR = 0.59, 95% CI 0.39 – 0.88, p = 0.01) and pneumonia (OR = 0.56, 95% CI 
0.32 – 0.98, p = 0.04). Probiotics did not provide statistically significant benefits in preventing 
urinary tract infections, leakage of anastomosis, and duration of postoperative pyrexia compared 
to the control group. Seven articles analyzed in the second meta-analysis showed probiotics to be 
useful in preventing postoperative infections with OR 0.5388 (95% CI, 0.4058-0.7154, P <0.0001). 
Conclusions. Combination of more than one strain of probiotics such as Lactobacillus and 
Bifidobacterium is promising for the prevention of infections in patients undergoing colorectal 
cancer surgery. 
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Introduction 
 
Cancer is one of the major health problems 
throughout the world and is the second leading cause 
of death in the United States. Colorectal cancer is the 
third leading cause of death from cancer in adults in 
the United States.1 In China, colorectal cancer ranks 
fifth for cancer deaths.2 In Indonesia, based on the 
2018 Basic Health Research, the prevalence of 
cancer increased compared to 2013 from 14 to 18 
per 10,000 lives with the highest prevalence at the 
age of 55-64 years.3  
Radical resection is the gold standard of 
treatment in most cases of colorectal cancer, 
although patients with colorectal cancer who 
undergo surgery often experience complications of 
postoperative infections. Postoperative infections 
can cause negative impact on long-term prognosis 
because they increase the morbidity and mortality of 
patients. Postoperative morbidity in colorectal 
cancer reaches 15-23.2%.4-6 Postoperative 
infections in colorectal cancer patients occur due to 
intestinal dysbiosis caused by perioperative stress, 
inflammatory responses and intestinal mucosal 
atrophy due to perioperative fasting and ischemia of 
the intestinal tract which induces translocation of 
intestinal microbiota into the intestinal mesenteric 
lymph glands to other organs.7-9  
Prevention of postoperative infections including 
restoration of normal intestinal microbiota and 
prevention of bacterial translocation must be 
undertaken to minimize postoperative 
complications.10 Probiotics are beneficial 
microorganisms in regulating homeostasis of 
microbiota, immunity and maintaining intestinal 
mucosal barrier. Administration of oral probiotics, 
such as Lactobacillus and Bifidobacterium is 
reported to be able to reach the colon and rectum in 
an active form to form colonies in the intestinal 
mucosa.11,12 The use of preoperative combination of 
several probiotics, such as Lactobacillus and 
Bifidobacterium can enhance the immune response 
and improve the postoperative intestinal microbiota 
environment. Although several studies have shown 
the benefits of probiotics in preventing postoperative 
complications of infection, the administration of 
perioperative probiotics in colorectal cancer patients 
is still controversial. Synbiotics are essentially a 
synergistic combination of probiotics and prebiotics. 
Research by Anderson, et al.13 concluded that the 
administration of synbiotics against the protection of 
the intestinal mucosal barrier did not produce 
meaningful results. Another research conducted by 
Consoli, et al.14 showed that administration of 
Saccharomyces boulardii can reduce levels of IL-23 
and IL-10 and inhibit T-cell activation, strengthen 
the intestinal barrier, and inhibit proinflammatory 
cytokine production. Research done by Gianotti, et 
al.15 showed that administration of Lactobacillus 
johnsonii (La) and Bifidobacterium longum 
(BB536) in colorectal cancer patients before surgery 
was able to reduce the number of intestinal 
pathogenic bacteria and modulate local immune 
responses. 
Research on the benefits of probiotics includes 
specific strains and doses that are adequate for 
cancer patients has not yet achieved conclusive 
results. Based on the literature, combination of more 
than one probiotic such as Lactobacillus and 
Bifidobacterium can improve the intestinal 
microbiota environment, the immune system and 
prevent complications, especially postoperative 
infections. For this reason, a literature study and 
critical study are needed to assess the benefits of 
probiotics in colorectal cancer patients in preventing 




A male patient aged 51 years came to the hospital 
with complaints of lower left abdominal pain arising 
and subsiding in the last 9 months. The patient also 
complained of difficulty defecating, small round 
hard, blackish-colored feces. CT scan results 
showed the patient had a tumor in the large intestine. 
The patient lost 15 kilograms in 1 year. Patient 
claimed to often consume grilled foods from a young 
age and rarely consume vegetables and fruits. The 
patient's blood pressure 120/80 mmHg, the pulse 
rate 84 times/minute, the respiratory rate 20 
times/minute, the temperature 360C.  
The conjunctiva anemic, the abdomen flat with 
normal bowel sounds. The patient's body weight 59 
kg, his body height 169cm, and body mass index 
20.6 kg/m2. Laboratory tests showed that Hb was 7.4 
g/dL, hematocrit 23%, leukocytes 2,900/µL, 
platelets 645,000/µL.  The results of a large bowel 
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biopsy showed a sigmoid colon adenocarcinoma. 
From the surgical department, the patient is planned 
to have a colon resection and colostomy. Therefore, 
a critical study will be conducted on the effectivity 
of administering probiotics to reduce complications 
of postoperative infections. 
 
Clinical question 
P: Adult colorectal cancer patient 
I: Patients receiving perioperative probiotics 
supplementation 
C: Patients who have not received perioperative 
probiotic supplementation 




The literature search was done on 3 databases  
(PubMed, Cochrane, and EBSCOhost) using 
advanced search on December 22, 2019. 
Critical review is carried out using the FAITH 





Article selection was based on the inclusion and 
exclusion criteria, which addressed the clinical 
question. The inclusion criteria were: 1) colorectal 
cancer patients over 18 years old; 2) patients got 
perioperative probiotics; 3) the study design used 
was a Randomized Controlled Trial, Cohort, or 
Case-control. The exclusion criteria were: 1) 
research in the form of reviews, comments, 
conference abstracts, letters, sections in a book or 
non-clinical study; 2) research that did not include 
the dose of probiotics used; 3) provision of 
probiotics used in combination with prebiotics or as 
synbiotics; 4) research that was not done in humans; 
5) research that did not mention the odds ratio (OR) 
or the difference in the standard mean difference 
(SMD); 6) research that did not include probiotic 
strain. 
 
Critical appraisal of Ouyang et al. 17 
 
This meta-analysis uses Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis 
(PRISMA) as a guide. The method section describes 
the search strategy by taking relevant studies from 
the Pubmed, Embase, Cochrane, and CNKI 
databases, but does not include data collection from 
relevant and unpublished studies. One of the 
weaknesses of this meta-analysis is that it only 
includes English and Chinese studies so that it is 
possible to lose important data in other language 
studies. Thirteen studies have been assessed as 
having complete, unbiased, and not selective data in 
their reporting. Twelve studies were also carried out 
by blinding. The study included in this meta-analysis 
has a low risk of bias involving 12 articles which are 
RCT design studies and 1 study which is a controlled 
clinical trial. The types of probiotics involved in this 
study varied greatly in terms of species, dosage, and 
duration of administration. The type of probiotics 
used are B. longum, B. bifidum, B. mesentericus, L. 
bulgaricus, L. acidophilus, L. plantarum, S. 
thermophilus, E. faecalis, C. butyricum, S. boulardii 
either given alone or in combination with a dose 
range of 106 – 1011 CFU/day. Probiotics were given 
2-4 times per day with a range of administration 
varies from 8 days before to 14 days postoperatively. 
The results of the meta-analysis study are presented 
in the form of a summary table and Forest plot. 
Heterogeneity tests have been carried out and no 
heterogeneity was observed among studies on the 
effects of preventing probiotics on postoperative 
infection rates (p = 0.60, I2 <0.01). Forest plots 
evaluate the preventive effects of probiotics on 
overall postoperative infections. Data from 13 
studies were collected to calculate pooled OR. The 
analysis model showed a pooled OR for overall 
infection was 0.51 with 95% CI 0.38 to 0.68. This 
meta-analysis concludes that the use of probiotics 
can prevent infections in patients undergoing CRC 
surgery and improve surgical recovery.  
 
Critical appraisal of Calaca et al.18 
 
This meta-analysis uses Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses 
(PRISMA) as a guide. The research was taken from 
5 databases namely Pubmed, Science Direct, Scielo, 
Scopus, and LILACS systematically from 2005 to 
2016. The search was not limited to English-
language studies, but also involved studies 
published in Spanish and Portuguese. The studies 
included in this meta-analysis are studies published 
 
World.Nutr.Journal | 103  
in leading journals, in the form of seven RCTs 
published from 2010 to 2016 and sample sizes 
ranging from 20 to 161 (average 90.1). The results 
of the meta-analysis study are presented in the form 
of a summary table and forest plot. Seven articles 
were analyzed to assess the effect of probiotics on 
infectious complications with I² = 14.3% (DF = 25, 
p = 0.2338) in the infection group. The type of 
probiotics used are B. longum, B. bifidum, L. 
johnsonii, L. acidophilus, L. plantarum, E. faecalis, 
C. butyricum either given alone or in combination 
with a dose range of 107 – 1011 CFU/day. Probiotics 
were given 2-4 times per day with a range of 
administration varies from 7 days before to 12 days 
postoperatively. Overall, the assessment of 
heterogeneity in this systematic review shows low 
heterogeneity. Two studies showed positive effect 
on probiotics for infectious complications with OR 
= 0.5388 (95% CI, 0.4058 – 0.7154, p <0.0001). 
This systematic reviews and meta-analysis show that 
the combination of more than one microorganism 
such as Lactobacillus and Bifidobacterium is 




Complications of postoperative infections, including 
surgical site infections, urinary tract infections, 
sepsis and pneumonia resulted in increased length of 
stay and morbidity in patients. The two meta-
analyses obtained from literature research and 
critical study are systematic reviews that are well-
prepared and meet critical reviews using the FAITH 
method. Both of meta-analyses, shown that 
combination of probiotics, such as Lactobacillus and 
Bifidobacterium play an important role in preventing 
infections after colorectal cancer surgery including 
overall infections, surgical site infections, and 
pneumonia.  
From the two systematic reviews conducted, it 
was found that four studies were similarly involved 
in both of meta-analyses. The probiotics used in 
these studies were E. faecalis, C. butyricum, B. 
mesentericus, B. bifidum, and L. plantarum.17 The 
meta-analysis conducted by Calaca, et al.17 involved 
7 studies and was published in 2017. One of the 
studies in the meta-analysis conducted by Calaca et 
al17 was RCT research conducted by Liu et al.19  
Research by Liu, et al.19 shows that administration 
of perioperative Lactobacillus plantarum, 
Lactobacillus acidophilus, Bifidobacterium longum 
can reduce the inflammatory response and decrease 
the length of stay in patients following colorectal 
cancer surgery. Microbial dysbiosis due to stress and 
inflammatory responses after colorectal cancer 
surgery improves with the administration of 
Lactobacillus plantarum, Lactobacillus acidophilus, 
Bifidobacterium longum. 
Analysis using the Forest plot found that the 
benefits of probiotics in preventing surgical site 
infections were only found in one out of  4 studies, 
so the results of the analysis were not statistically 
significant (OR 0.6538, 95% CI 0.3951 –  1.0817).8 
The results of the analysis of the effectivity of the 
administration of probiotics to the detection of 
bacteria in the blood taken from 4 articles gave 
significant results with OR 0.4069 (95% CI, 0.2662 
– 0.6222, P <0.0001). Seven articles analyzed to 
assess the benefits of probiotics in preventing 
postoperative infections gave significant results with 
OR 0.5388 (95% CI, 0.4058-0.7154, P <0.0001). 
A meta-analysis carried out by Ouyang, et 
al.17 involving 13 studies showed that the preventive 
effect of probiotics (B. longum, B. bifidum, B. 
mesentericus, L. bulgaricus, L. acidophilus, L. 
plantarum, S. thermophilus, E. faecalis, C. 
butyricum, S. boulardii) on anastomotic leakage and 
urinary tract infections did not show significant 
results, possibly because collection of more updated 
researches may lead to the main differences this 
meta-analysis compared to previous meta-analysis. 
An evaluation using the Forrest plot showed that 
probiotics (B. longum, B. bifidum, B. mesentericus, 
L. bulgaricus, L. acidophilus, L. plantarum, S. 
thermophilus, E. faecalis, C. butyricum, S. 
boulardii) had an overall preventive effect on 
postoperative infections (OR 0.51, 95% CI 0.38 – 
0.68). Preventive effects of probiotics on surgical 
site infections in 9 studies showed significant results 
with OR 0.59 (95% CI 0.39 – 0.88) as well as against 
pneumonia prevention (OR 0.52 with 95% CI 0.32 – 
0.98).17  
  There are several weaknesses to be noted in 
this meta-analysis. First, this study only took data 
from published research without taking data from 
other unpublished studies and therefore could result 
in loss of data in other relevant studies. Secondly, 
this study only analyze the individual effects of 
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probiotics without involving research with 
prebiotics or as synbiotics that might affect the 
results of the analysis even though the role of 
prebiotics or synbiotics in the prevention of 
postoperative infections is also still not conclusive. 
Third, some important data such as serum antibody 
concentration and inflammatory factors are only 
available in a number of studies so no in-depth 
analysis is performed. Fourth, the probiotics strain 
and doses in several studies collected were not 
consistent with each other. Several studies that 
combined probiotics with other treatment should be 
excluded so that they might not induce confounding 




Combination of more than one strain of probiotics 
such as Lactobacillus and Bifidobacterium is 
promising for the prevention of infections in patients 
undergoing colorectal cancer surgery which 
provides benefits in post-surgical recovery and 
decreases the length of treatment. The dose that can 
be given ranges from 106 – 1011 CFU/day with the 
frequency of administration 2-4 times per day and 
range of administration varies from 8 days before to 
14 days postoperatively. The administration of 
probiotics must still be adjusted to the patient's 
condition and the therapy given. Further research is 
needed to determine the best type of probiotic strain 
along with the optimal dosage and duration of 
administration to prevent complications of 








Table 1. Terminology 
 
DatabaseDatabase TerminologySearch Strategy Hitsts 
PubMed Search ((prevent[Title/Abstract] OR treat[Title/Abstract]) AND 
(probiotics[Title/Abstract] OR probiotics[MeSH Terms] OR 
lactobacillus[MeSH Terms] OR lactobacillus[Title/Abstract])) AND ((colon 
cancer[Title/Abstract] OR rectal cancer[Title/Abstract]) OR colorectal 
cancer[Title/Abstract]) 
71 
Cochrane ID Search 
#1 (prevent):ti,ab,kw OR (treat):ti,ab,kw (Word variations have been searched) 
#2 (lactobacillus):ti,ab,kw OR (probiotics):ti,ab,kw (Word variations have 
been searched) 
#3 (colon cancer):ti,ab,kw OR (rectal cancer):ti,ab,kw OR (colorectal 
cancer):ti,ab,kw (Word variations have been searched) 
#4 #1 AND #2 AND #3 
71 
EBSCOhost Search Alert: ("probiotics” OR “lactobacillus”) AND ("treat" OR "prevent") 
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Figure 1. PRISMA Flowchart 
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